Physician profile
Jordan M Reader
NPI 1770146862
$1,094.60
in general payments reported to CMS, 2019-2025
16 companies · $832 in 2025
The $832 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.50 · 2024: $200 · 2025: $832.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,032.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,032.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $139.57 | 2024-2025 | |
| Amgen INC. | $111.09 | 2024-2025 | Repatha, Otezla, Evenity |
| Pfizer INC. | $103.03 | 2024-2025 | |
| Astrazeneca Pharmaceuticals Lp | $93.35 | 2025 | Breztri |
| Viatris Specialty LLC | $80.67 | 2025 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $73.02 | 2025 | Jardiance |
| Radius Health, INC. | $66.09 | 2025 | Tymlos |
| Novo Nordisk INC | $65.60 | 2025 | Ozempic, Rybelsus, Wegovy |
| Acera Surgical, INC. | $62.50 | 2019 | |
| Glaxosmithkline, LLC. | $56.82 | 2024-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Exact Sciences Corporation | $49.75 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Medtronic, INC. | $46.30 | 2024 | Accurian |
| Abbvie INC. | $46.03 | 2025 | |
| Lilly USA, LLC | $42.02 | 2024-2025 | Mounjaro, Zepbound |
| Biotronik Nro, INC. | $38.58 | 2025 | Prospera |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $20.18 | 2025 | Loreev Xr, Teriparatide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Reader listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.